AURA
Price
$7.50
Change
+$0.30 (+4.16%)
Updated
Mar 4, 04:59 PM (EDT)
Capitalization
374.14M
8 days until earnings call
DAWN
Price
$8.61
Change
+$0.36 (+4.36%)
Updated
Mar 4, 04:59 PM (EDT)
Capitalization
918.27M
64 days until earnings call
Ad is loading...

AURA vs DAWN

Header iconAURA vs DAWN Comparison
Open Charts AURA vs DAWNBanner chart's image
Aura Biosciences
Price$7.50
Change+$0.30 (+4.16%)
Volume$1.21K
Capitalization374.14M
Day One Biopharmaceuticals
Price$8.61
Change+$0.36 (+4.36%)
Volume$76.51K
Capitalization918.27M
AURA vs DAWN Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. DAWN commentary
Mar 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and DAWN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 05, 2025
Stock price -- (AURA: $7.21 vs. DAWN: $8.25)
Brand notoriety: AURA and DAWN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 90% vs. DAWN: 251%
Market capitalization -- AURA: $374.14M vs. DAWN: $918.27M
AURA [@Biotechnology] is valued at $374.14M. DAWN’s [@Biotechnology] market capitalization is $918.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileDAWN’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • DAWN’s FA Score: 0 green, 5 red.
According to our system of comparison, both AURA and DAWN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 3 TA indicator(s) are bullish while DAWN’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 3 bullish, 5 bearish.
  • DAWN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -2.17% price change this week, while DAWN (@Biotechnology) price change was -32.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -9.65%, and the average quarterly price growth was -5.79%.

Reported Earning Dates

AURA is expected to report earnings on May 08, 2025.

DAWN is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DAWN($918M) has a higher market cap than AURA($374M). AURA YTD gains are higher at: -12.287 vs. DAWN (-34.886). AURA has higher annual earnings (EBITDA): -91.84M vs. DAWN (-210.08M). DAWN has more cash in the bank: 558M vs. AURA (174M). DAWN has less debt than AURA: DAWN (2.62M) vs AURA (19.1M). DAWN has higher revenues than AURA: DAWN (102M) vs AURA (0).
AURADAWNAURA / DAWN
Capitalization374M918M41%
EBITDA-91.84M-210.08M44%
Gain YTD-12.287-34.88635%
P/E RatioN/AN/A-
Revenue0102M-
Total Cash174M558M31%
Total Debt19.1M2.62M730%
TECHNICAL ANALYSIS
Technical Analysis
AURADAWN
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMAAX14.93N/A
N/A
Gabelli Entpr Mergers & Acquisitions A
PPQJX3.48N/A
N/A
Principal MidCap Growth III J
FBSIX37.79N/A
N/A
Franklin Mutual U.S. Mid Cap Value R6
ACUIX38.11-0.30
-0.78%
Columbia Dividend Opportunity C
JMVZX32.58-0.36
-1.09%
JPMorgan Mid Cap Value R2

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-8.94%
VCYT - DAWN
43%
Loosely correlated
-3.45%
DNLI - DAWN
42%
Loosely correlated
-8.27%
ACLX - DAWN
41%
Loosely correlated
-3.38%
KROS - DAWN
40%
Loosely correlated
+0.36%
AURA - DAWN
37%
Loosely correlated
-3.74%
More